Disentangling the influence of three major threats on the demography of an albatross community

Climate change, fisheries and invasive species represent three pervasive threats to seabirds, globally. Understanding the relative influence and compounding nature of marine and terrestrial threats on the demography of seabird communities is vital for evidence-based conservation. Using 20 years of capture-mark-recapture data from four sympatric species of albatross (black-browed Thalassarche melanophris, gray-headed T. chrysostoma, light-mantled Phoebetria palpebrata and wandering Diomedea exulans) at subantarctic Macquarie Island, we quantified the temporal variability in survival, breeding probability and success. In three species (excluding the wandering albatross because of their small population), we also assessed the influence of fisheries, oceanographic and terrestrial change on these rates. The Southern Annular Mode (SAM) explained 20.87–29.38% of the temporal variability in survival in all three species and 22.72–28.60% in breeding success for black-browed and gray-headed albatross, with positive SAM events related to higher success. The El Niño Southern Oscillation (ENSO) Index explained 21.14–44.04% of the variability in survival, with higher survival rates following La Niña events. For black-browed albatrosses, effort in south-west Atlantic longline fisheries had a negative relationship with survival and explained 22.75–32.21% of the variability. Whereas increased effort in New Zealand trawl fisheries were related to increases in survival, explaining 21.26–28.29 % of variability. The inclusion of terrestrial covariates, reflecting extreme rainfall events and rabbit-driven habitat degradation, explained greater variability in trends breeding probability than oceanographic or fisheries covariates for all three species. These results indicate managing drivers of demographic trends that are most easily controlled, such as fisheries and habitat degradation, will be a viable option for some species (e.g., black-browed albatross) but less effective for others (e.g., light-mantled albatross). Our results illustrate the need to integrate fisheries, oceanographic and terrestrial processes when assessing demographic variability and formulating the appropriate management response

A comprehensive large-scale assessment of fisheries bycatch risk to threatened seabird populations

1.Incidental mortality (bycatch) in fisheries remains the greatest threat to many large marine vertebrates and is a major barrier to fisheries sustainability. Robust assessments of bycatch risk are crucial for informing effective mitigation strategies, but are hampered by missing information on the distributions of key life‐history stages (adult breeders and non‐breeders, immatures and juveniles). 2.Using a comprehensive biologging dataset (1,692 tracks, 788 individuals) spanning all major life‐history stages, we assessed spatial overlap of four threatened seabird populations from South Georgia, with longline and trawl fisheries in the Southern Ocean. We generated monthly population‐level distributions, weighting each life‐history stage according to population age structure based on demographic models. Specifically, we determined where and when birds were at greatest potential bycatch risk, and from which fleets. 3.Overlap with both pelagic and demersal longline fisheries was highest for black‐browed albatrosses, then white‐chinned petrels, wandering and grey‐headed albatrosses, whereas overlap with trawl fisheries was highest for white‐chinned petrels. 4.Hotspots of fisheries overlap occurred in all major ocean basins, but particularly the south‐east and south‐west Atlantic Ocean (longline and trawl) and south‐west Indian Ocean (pelagic longline). Overlap was greatest with pelagic longline fleets in May–September, when fishing effort south of 25°S is highest, and with demersal and trawl fisheries in January–June. Overlap scores were dominated by particular fleets: pelagic longline—Japan, Taiwan; demersal longline and trawl—Argentina, Namibia, Falklands, South Africa; demersal longline—Convention for Conservation of Antarctic Marine Living Resources (CCAMLR) waters, Chile, New Zealand. 5.Synthesis and applications. We provide a framework for calculating appropriately weighted population‐level distributions from biologging data, which we recommend for future fisheries bycatch risk assessments. Many regions of high spatial overlap corresponded with high seabird bycatch rates recorded by on‐board observers, indicating that our approach reliably mapped relative bycatch risk at large spatial scales. Implementation of effective bycatch mitigation in these high‐risk regions varies considerably. Although potential bycatch risk appears to have decreased since the early 2000s, albatross and petrel populations from South Georgia and elsewhere are still declining, emphasizing the need for much improved observer coverage and monitoring of compliance with bycatch regulations

The development and validation of a scoring tool to predict the operative duration of elective laparoscopic cholecystectomy

Background: The ability to accurately predict operative duration has the potential to optimise theatre efficiency and utilisation, thus reducing costs and increasing staff and patient satisfaction. With laparoscopic cholecystectomy being one of the most commonly performed procedures worldwide, a tool to predict operative duration could be extremely beneficial to healthcare organisations. Methods: Data collected from the CholeS study on patients undergoing cholecystectomy in UK and Irish hospitals between 04/2014 and 05/2014 were used to study operative duration. A multivariable binary logistic regression model was produced in order to identify significant independent predictors of long (> 90 min) operations. The resulting model was converted to a risk score, which was subsequently validated on second cohort of patients using ROC curves. Results: After exclusions, data were available for 7227 patients in the derivation (CholeS) cohort. The median operative duration was 60 min (interquartile range 45–85), with 17.7% of operations lasting longer than 90 min. Ten factors were found to be significant independent predictors of operative durations > 90 min, including ASA, age, previous surgical admissions, BMI, gallbladder wall thickness and CBD diameter. A risk score was then produced from these factors, and applied to a cohort of 2405 patients from a tertiary centre for external validation. This returned an area under the ROC curve of 0.708 (SE = 0.013, p  90 min increasing more than eightfold from 5.1 to 41.8% in the extremes of the score. Conclusion: The scoring tool produced in this study was found to be significantly predictive of long operative durations on validation in an external cohort. As such, the tool may have the potential to enable organisations to better organise theatre lists and deliver greater efficiencies in care

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016) : part two

Background The immunological escape of tumors represents one of the main ob- stacles to the treatment of malignancies. The blockade of PD-1 or CTLA-4 receptors represented a milestone in the history of immunotherapy. However, immune checkpoint inhibitors seem to be effective in specific cohorts of patients. It has been proposed that their efficacy relies on the presence of an immunological response. Thus, we hypothesized that disruption of the PD-L1/PD-1 axis would synergize with our oncolytic vaccine platform PeptiCRAd. Methods We used murine B16OVA in vivo tumor models and flow cytometry analysis to investigate the immunological background. Results First, we found that high-burden B16OVA tumors were refractory to combination immunotherapy. However, with a more aggressive schedule, tumors with a lower burden were more susceptible to the combination of PeptiCRAd and PD-L1 blockade. The therapy signifi- cantly increased the median survival of mice (Fig. 7). Interestingly, the reduced growth of contralaterally injected B16F10 cells sug- gested the presence of a long lasting immunological memory also against non-targeted antigens. Concerning the functional state of tumor infiltrating lymphocytes (TILs), we found that all the immune therapies would enhance the percentage of activated (PD-1pos TIM- 3neg) T lymphocytes and reduce the amount of exhausted (PD-1pos TIM-3pos) cells compared to placebo. As expected, we found that PeptiCRAd monotherapy could increase the number of antigen spe- cific CD8+ T cells compared to other treatments. However, only the combination with PD-L1 blockade could significantly increase the ra- tio between activated and exhausted pentamer positive cells (p= 0.0058), suggesting that by disrupting the PD-1/PD-L1 axis we could decrease the amount of dysfunctional antigen specific T cells. We ob- served that the anatomical location deeply influenced the state of CD4+ and CD8+ T lymphocytes. In fact, TIM-3 expression was in- creased by 2 fold on TILs compared to splenic and lymphoid T cells. In the CD8+ compartment, the expression of PD-1 on the surface seemed to be restricted to the tumor micro-environment, while CD4 + T cells had a high expression of PD-1 also in lymphoid organs. Interestingly, we found that the levels of PD-1 were significantly higher on CD8+ T cells than on CD4+ T cells into the tumor micro- environment (p < 0.0001). Conclusions In conclusion, we demonstrated that the efficacy of immune check- point inhibitors might be strongly enhanced by their combination with cancer vaccines. PeptiCRAd was able to increase the number of antigen-specific T cells and PD-L1 blockade prevented their exhaus- tion, resulting in long-lasting immunological memory and increased median survival

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Background Previous evidence indicates that adjuvant, short-course androgen deprivation therapy (ADT) improves metastasis-free survival when given with primary radiotherapy for intermediate-risk and high-risk localised prostate cancer. However, the value of ADT with postoperative radiotherapy after radical prostatectomy is unclear. Methods RADICALS-HD was an international randomised controlled trial to test the efficacy of ADT used in combination with postoperative radiotherapy for prostate cancer. Key eligibility criteria were indication for radiotherapy after radical prostatectomy for prostate cancer, prostate-specific antigen less than 5 ng/mL, absence of metastatic disease, and written consent. Participants were randomly assigned (1:1) to radiotherapy alone (no ADT) or radiotherapy with 6 months of ADT (short-course ADT), using monthly subcutaneous gonadotropin-releasing hormone analogue injections, daily oral bicalutamide monotherapy 150 mg, or monthly subcutaneous degarelix. Randomisation was done centrally through minimisation with a random element, stratified by Gleason score, positive margins, radiotherapy timing, planned radiotherapy schedule, and planned type of ADT, in a computerised system. The allocated treatment was not masked. The primary outcome measure was metastasis-free survival, defined as distant metastasis arising from prostate cancer or death from any cause. Standard survival analysis methods were used, accounting for randomisation stratification factors. The trial had 80% power with two-sided α of 5% to detect an absolute increase in 10-year metastasis-free survival from 80% to 86% (hazard ratio [HR] 0·67). Analyses followed the intention-to-treat principle. The trial is registered with the ISRCTN registry, ISRCTN40814031, and ClinicalTrials.gov, NCT00541047. Findings Between Nov 22, 2007, and June 29, 2015, 1480 patients (median age 66 years [IQR 61–69]) were randomly assigned to receive no ADT (n=737) or short-course ADT (n=743) in addition to postoperative radiotherapy at 121 centres in Canada, Denmark, Ireland, and the UK. With a median follow-up of 9·0 years (IQR 7·1–10·1), metastasis-free survival events were reported for 268 participants (142 in the no ADT group and 126 in the short-course ADT group; HR 0·886 [95% CI 0·688–1·140], p=0·35). 10-year metastasis-free survival was 79·2% (95% CI 75·4–82·5) in the no ADT group and 80·4% (76·6–83·6) in the short-course ADT group. Toxicity of grade 3 or higher was reported for 121 (17%) of 737 participants in the no ADT group and 100 (14%) of 743 in the short-course ADT group (p=0·15), with no treatment-related deaths. Interpretation Metastatic disease is uncommon following postoperative bed radiotherapy after radical prostatectomy. Adding 6 months of ADT to this radiotherapy did not improve metastasis-free survival compared with no ADT. These findings do not support the use of short-course ADT with postoperative radiotherapy in this patient population

Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

Background Previous evidence supports androgen deprivation therapy (ADT) with primary radiotherapy as initial treatment for intermediate-risk and high-risk localised prostate cancer. However, the use and optimal duration of ADT with postoperative radiotherapy after radical prostatectomy remains uncertain. Methods RADICALS-HD was a randomised controlled trial of ADT duration within the RADICALS protocol. Here, we report on the comparison of short-course versus long-course ADT. Key eligibility criteria were indication for radiotherapy after previous radical prostatectomy for prostate cancer, prostate-specific antigen less than 5 ng/mL, absence of metastatic disease, and written consent. Participants were randomly assigned (1:1) to add 6 months of ADT (short-course ADT) or 24 months of ADT (long-course ADT) to radiotherapy, using subcutaneous gonadotrophin-releasing hormone analogue (monthly in the short-course ADT group and 3-monthly in the long-course ADT group), daily oral bicalutamide monotherapy 150 mg, or monthly subcutaneous degarelix. Randomisation was done centrally through minimisation with a random element, stratified by Gleason score, positive margins, radiotherapy timing, planned radiotherapy schedule, and planned type of ADT, in a computerised system. The allocated treatment was not masked. The primary outcome measure was metastasis-free survival, defined as metastasis arising from prostate cancer or death from any cause. The comparison had more than 80% power with two-sided α of 5% to detect an absolute increase in 10-year metastasis-free survival from 75% to 81% (hazard ratio [HR] 0·72). Standard time-to-event analyses were used. Analyses followed intention-to-treat principle. The trial is registered with the ISRCTN registry, ISRCTN40814031, and ClinicalTrials.gov , NCT00541047 . Findings Between Jan 30, 2008, and July 7, 2015, 1523 patients (median age 65 years, IQR 60–69) were randomly assigned to receive short-course ADT (n=761) or long-course ADT (n=762) in addition to postoperative radiotherapy at 138 centres in Canada, Denmark, Ireland, and the UK. With a median follow-up of 8·9 years (7·0–10·0), 313 metastasis-free survival events were reported overall (174 in the short-course ADT group and 139 in the long-course ADT group; HR 0·773 [95% CI 0·612–0·975]; p=0·029). 10-year metastasis-free survival was 71·9% (95% CI 67·6–75·7) in the short-course ADT group and 78·1% (74·2–81·5) in the long-course ADT group. Toxicity of grade 3 or higher was reported for 105 (14%) of 753 participants in the short-course ADT group and 142 (19%) of 757 participants in the long-course ADT group (p=0·025), with no treatment-related deaths. Interpretation Compared with adding 6 months of ADT, adding 24 months of ADT improved metastasis-free survival in people receiving postoperative radiotherapy. For individuals who can accept the additional duration of adverse effects, long-course ADT should be offered with postoperative radiotherapy. Funding Cancer Research UK, UK Research and Innovation (formerly Medical Research Council), and Canadian Cancer Society

Optimal harvesting models for metapopulations / Geoffrey N. Tuck.

Bibliography: leaves 217-238.ix, 238 leaves ; 30 cm.Thesis (Ph.D.)--University of Adelaide, Dept. of Applied Mathematics, 1995

South Africa demersal longline (kingklip)

South Africa demersal kingklip (modelled

Argentina demersal longline

Argentina demersal longline (modelled

Chile demersal longline

Chilean demersal and pelagic (Swordfish) longline (modelled